Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Payables (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Payables for 3 consecutive years, with $116.2 million as the latest value for Q4 2025.

  • Quarterly Payables rose 13.46% to $116.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $116.2 million through Dec 2025, up 13.46% year-over-year, with the annual reading at $116.2 million for FY2025, 13.46% up from the prior year.
  • Payables hit $116.2 million in Q4 2025 for Guardian Pharmacy Services, down from $121.7 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $121.7 million in Q3 2025 to a low of $89.6 million in Q4 2023.
  • Historically, Payables has averaged $107.0 million across 3 years, with a median of $105.0 million in 2025.
  • Biggest five-year swings in Payables: rose 14.33% in 2024 and later increased 8.34% in 2025.
  • Year by year, Payables stood at $89.6 million in 2023, then grew by 14.33% to $102.4 million in 2024, then grew by 13.46% to $116.2 million in 2025.
  • Business Quant data shows Payables for GRDN at $116.2 million in Q4 2025, $121.7 million in Q3 2025, and $105.0 million in Q2 2025.